2023 BIO International Convention, Meet the ASC Team in Boston! | June 5-8, 2023

Meet our team at the 2023 BIO International Convention. Schedule your meeting with our experts to learn about Applied StemCell's custom CRO/CDMO service options and how we can help support your cell therapy projects.

When: June 5-8, 2023

Where: Boston, MA

Register: https://www.bio.org/events/bio-international-convention/registration-information?utm_medium=paid-search&utm_source=google&utm_campaign=international-convention-2023-search&utm_term=bio%20international%20convention%20boston&gclid=EAIaIQobChMIusqP6JbV_gIVVAutBh2YywEAEAAYASAAEgKpI_D_BwE 

About Applied StemCell, Inc.

ASC has a Drug Manufacturing License from the California Department of Public Health, Food and Drug Branch (FDB). It has a Quality Management System (ISO 13485 certified) and established cGMP-compliant protocols for cell banking and manufacturing, iPSC generation, genome editing, iPSC differentiation, and cell product manufacturing. With over 13 years of gene-editing and stem cell expertise, ASC offers comprehensive and customized cell and gene CRO/CDMO solutions. Its core iPSC and genome editing (CRISPR and TARGATTTM) technologies, facilitate site-specific, large cargo (up to 20kb) transgene integration and the development of allogenic cell products.

Media Contact:
Maki Ogawa
Marketing Director, Applied StemCell, Inc.
408-773-8007
maki.ogawa@appliedstemcell.com

Google